Global Nebulizer Market Size, Share, Industry Trends Analysis 2020, & Forecast 2021-2026 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Global Nebulizer Market


The global Nebulizer market size is projected to reach US$ 1440.01 million by 2026, from US$ 986.89 million in 2020, at a CAGR of 6.5% during 2021-2026. High prevalence of chronic respiratory diseases, increasing demand for home healthcare, and rising geriatric population across the globe are some of the major factors driving the growth. Technological advancements are anticipated to further fuel the growth.

High prevalence of chronic diseases is one of the major driving factors for the market growth. For instance, as per the Global Burden of Disease Study, an estimated 251 million people worldwide were suffering from Chronic Obstructive Pulmonary Disease (COPD) in 2016. In addition, as per the World Health Organization (WHO), around 3.17 million deaths were reported due to COPD in 2015.

Initiatives such as the Global Alliance against Chronic Respiratory Diseases are likely to improve diagnosis and treatment rates of respiratory disorders, which may in turn boost the nebulizer market. Furthermore, as per a 2015 report by WHO, each year 16 million people die due to non-communicable diseases before the age of 70.
In addition, factors such as rise in obesity, unhealthy eating habits, lack of physical activity, and overconsumption of tobacco and alcohol are also likely to lead to high prevalence of respiratory disorders. This factor may contribute to growth of the market over the forecast period.

Market Segmentation, Outlook & Viewpoint: Global Nebulizer Market

Type Market Segmentation & Outlook (Revenue, USD Million; 2014 - 2026)

  
Pneumatic
  
Standalone
  
Portable
  
Mesh
  
Ultrasonic
  
Standalone
  
Portable

Key Players, Recent Developments & Regional Insights: Global Nebulizer Market

Based on type, the market is trifurcated into pneumatic, mesh, and ultrasonic nebulizer. The pneumatic and ultrasonic nebulizer segments are sub-segmented into standalone and portable. Pneumatic nebulizer held a dominant share in 2018 owing to the high prevalence of respiratory disorders among aging population.

Mesh nebulizer segment is expected to witness the fastest growth over the forecast period. These products can be static as well as vibrating. Static mesh nebulizer apply a force on the liquid drug to push it through a static mesh, whereas in vibrating mesh nebulizer use mesh vibration or deformation to push the liquid drug through the mesh. Some of the products offered by the key players in the market are Omron Corporations MicroAIR U100, Allied Healthcares Schuco S5000 Nebulizer, and Philips Healthcares Aeroneb Go.

Regional Insights

North America accounted for the largest market share in 2018 and is estimated to witness significant growth over the forecast period, owing to the rise in incidence of chronic respiratory diseases. According to the Centers for Disease Control and Prevention (CDC), COPD was estimated as the third leading causes of death in U.S. in 2014. Moreover, rise in geriatric population in North America is resulting into rising number of respiratory disorders and surgeries, which is also likely to boost the regional growth.According to Statistics Canada, in July 2015, approximately 16.1% of the population was aged 65 years and over. In addition, healthcare cost containment issues post the economic crisis in U.S. have compelled the government to introduce new strategies to reduce patient stays in hospitals and hospital readmissions. This has resulted into increase in homecare services, which, in turn, has created a favorable environment for the growth.

Asia Pacific region is expected to exhibit the fastest CAGR during the forecast period due to rising geriatric population and cases of respiratory diseases. COPD is the seventh most common cause of death in Japan according to Japans Ministry of Health, Labor and Welfare. In addition, according to the Institute for Health Metrics and Evaluation, in Japan, COPD cases increased by 24.2% from 2005 to 2016. Moreover, a significant percentage of population of countries such as India and China has been estimated to suffer from pulmonary diseases. According to the WHO, in 2017, around 90.0% of deaths resulting from COPD occurred in middle- and low-income countries. It also stated that countries, such as China and India, single-handedly accounted for about 66.0% of total mortality resulting from COPD. Thus, such high number of cases of respiratory diseases is expected to boost the regional market. Rise in healthcare expenditure and patient awareness is also anticipated to propel the growth.

Nebulizer Market Share Insights

Prominent key players include Omron Corporation; Koninklijke Philips N.V.; PARI Pharma; and Allied Healthcare Products, Inc. Key players are involved in adopting various strategies such as mergers and acquisitions, product launches, and partnerships to strengthen their market position.

In October 2020, PARI Pharma GmbH, a company focused on the development, manufacturing and commercialization of advanced aerosol delivery systems based on eFlow Technology, announced the issue of the CE declaration of conformity for its optimised eFlow Technology LAMIRA Nebuliser System. It is intended only for use with ARIKAYCE Liposomal 590 mg Nebuliser Dispersion. While PARI issued the CE declaration of conformity in compliance with the Medical Devices Directive (93/42/EEC) for LAMIRA, Insmed was granted the marketing authorisation for ARIKAYCE by the European Commission (EC).

ARIKAYCE is the first inhaled liposomal dispersion approved by the EC and the first and only therapy in the European Union indicated for the treatment of non-tuberculous mycobacterial (NTM) lung infections caused by Mycobacterium avium complex (MAC) in adults with limited treatment options who do not have cystic fibrosis (CF). Consideration should be given to official guidance on the appropriate use of antibacterial agents. The LAMIRA Nebuliser System is specifically optimised for the administration of ARIKAYCE, and patented features are included. Research team leveraged laser drilled membrane technology and patented aerosol chamber to optimize the delivery of ARIKAYCEs unique liposomal formulation for the benefit of patients with a high need for therapies.

The LAMIRA Nebuliser System is the sixth drug-specific eFlow Technology device to become commercially available. Since it is used to treat NTM patients LAMIRA extends the range of indications for which optimised eFlow Technology nebulisers are used. Following the approval of ARIKAYCE and LAMIRA by the US FDA in 2018, they  partnershed with Insmed to have the opportunity to make the first approved treatment available for these seriously ill patients in Europe

In June 2016, PARI Pharma eFlow technology was used in two pivotal phase III trials of SUN-101. By pairing with SUN-101 and eFlow technology, Sunovion intends to combine the attributes of an inhaler and a nebulizer in a single system.

Key Insights Covered: Global Nebulizer Market

1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue and growth rate) of Nebulizer industry.
2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Nebulizer industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue and growth rate) of Nebulizer industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Nebulizer industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Nebulizer industry.

Research Methodology: Global Nebulizer Market

  
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among other